Who is the CEO of CRISM Therapeutics Corporation?

The CEO of CRISM Therapeutics Corporation is Robin Jay Young.

What industry does CRISM Therapeutics Corporation belong to?

CRISM Therapeutics Corporation operates in the Biotechnology industry within the Healthcare sector.

Where is CRISM Therapeutics Corporation headquartered?

CRISM Therapeutics Corporation is headquartered at Kingston Chambers, Road Town, VG.

What is the IPO date of CRISM Therapeutics Corporation?

CRISM Therapeutics Corporation went public on October 17, 2003.

How many employees does CRISM Therapeutics Corporation have?

CRISM Therapeutics Corporation has approximately 4 full-time employees.

CRISM Therapeutics Corporation

CRTX.L•LSE

Healthcare

Biotechnology

£10.75

£0.00(0.00%)

CRISM Therapeutics Corporation (CRTX.L) Company Profile & Overview

Explore CRISM Therapeutics Corporation’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

CRISM Therapeutics Corporation (CRTX.L) Company Profile & Overview

CRISM Therapeutics Corporation focuses on drug delivery technology to improve the clinical performance of cancer drugs as treatments for solid tumors. Its lead product, ChemoSeed that can be implanted directly into a tumor or the resection margin following the removal of a tumor, ensuring effective therapeutic concentrations of chemotherapy drugs directly reach the tumor tissue. Its ChemoSeed used for treatment of gliomas, a brain tumor. The company was founded in 2016 and is based in Road Town, the British Virgin Islands.

SectorHealthcare

IndustryBiotechnology

CEORobin Jay Young

Contact Information

https://www.crismtherapeutics.com

Kingston Chambers, Road Town

Company Facts

4 Employees

IPO DateOct 17, 2003

CountryVG

Actively Trading

Frequently Asked Questions

;